Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia
Author:
Affiliation:
1. GlaxoSmithKline; USA
2. Novartis Pharmaceuticals Corp; East Hanover USA
3. Novartis Pharma AG; Basel Switzerland
Funder
GlaxoSmithKline
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1066/fullpdf
Reference22 articles.
1. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies;Aledort;Am. J. Hematol.,2004
2. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura;El-Bostany;Blood Coagul. Fibrinolysis,2008
3. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2009
4. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy;British Committee for Standards in Haematology General Haematology Task Force;Br. J. Haematol.,2003
5. Idiopathic thrombocytopenia, initial illness and long term follow up;Walker;Arch. Dis. Child.,1984
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia;The Journal of Clinical Pharmacology;2024-03-18
2. Clinical signs and treatment of New-onset Bone marrow failure associated SARS-CoV-2 infection in Children : a single institution prospective cohort study .;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29
3. Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt;Annals of Hematology;2023-09-13
4. Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy;Hematology;2023-05-18
5. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia;Blood Advances;2023-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3